Cite

HARVARD Citation

    Karmani, L. et al. (2014). 89Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. Nanomedicine. pp. 1923-1937. [Online]. 
  
Back to record